Advisers and Service Providers

Sub Menu
Recent News
- February 2010
  
  Genscreen announces that the in-house RESET project has completed initial testing and shall be renamed “Hervian”
- January 2010
  
  Ian Dixon, CEO of Genscreen Pty Ltd, announces that Genscreen is presently having TR400 drugs sythesised by a contractor. It is anticipated that screening results will be ready for review by March 2010
- December 2009
  
  Genscreen announces the interim results of its preclinical development projects
- August 2009
  
  Genscreen commences work with Qubist Molecular Design (www.qubistmd.com)
- May 2009
  
  Genscreen Pty Ltd announces that it has reduced its operations to concentrate on core activities
News Archives
Admin Area
- Log in
- XHTML

Advisers and Service Providers

Legal
Middletons
http://www.middletons.com.au

Patent Attorney
Davies Collison Cave
http://www.davies.com.au

Bank
Commonwealth Bank
http://www.commbank.com.au

Accountants
Hains Muir Hill
http://www.hmh.com.au

Molecular Modelling
Qubist Molecular Design
http://www.qubistmd.com